According to this, it is reasonable to expect that besides the molecular defects in ABCA1, the clinical presentation of TD patients is also influenced by other factors such as transcriptional or posttranscriptional elements, other genes that participate in cholesterol efflux, nutritional factors, and age. This evidence concerns the gene ABCA1 and thanatophoric dysplasia.